Observational study of blood clotting and bleeding disorders in Chinese patients
Official title: Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Run by Peking University People's Hospital · NCT06727669 · Data updated 2026-11-12
This study looks at blood clotting and bleeding problems in Chinese patients to see how common they are and what factors might affect them.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Peking University People's Hospital Academic / other |
| Locations | 5 sites (Beijing, Beijing Municipality and 4 other locations) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2030 |
| Registry record updated | December 11, 2024 |
| Trial ID | NCT06727669 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with thrombosis and hemostasis diseases.
✕Probably not a fit
Patients who have serious concomitant diseases or those unable to comply with study requirements may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, prospective, longitudinal observational cohort study aims to investigate thrombosis and hemostasis diseases among Chinese patients. It will collect comprehensive data on patient demographics, diagnostic and treatment information, and medical expenses from medical records. The study will analyze the incidence and risk factors associated with these diseases, as well as treatment methods and patient prognosis through follow-up questionnaires. By focusing on a large-scale cohort, this study seeks to fill the gaps left by previous smaller studies.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of thrombosis and hemostasis diseases, enhancing patient outcomes.
How similar studies have gone: While there have been smaller studies on these conditions, this large-scale, comprehensive approach is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who were diagnosed as thrombosis and hemostasis diseases. Exclusion Criteria: * Long-term follow-up information for patients is not available for any reason, such as not being available or having a serious concomitant disease. * Patients with alcohol and drug addictions or mental illness affect their ability to comply with study requirements. * According to the investigator, there are conditions that may endanger the patient's safety or affect his/her compliance.
Where it's running
-
Peking University Insititute of Hematology, Peking University People's Hospital
Beijing, Beijing Municipality, China Recruiting -
Department of Hematology, Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China Not yet recruiting -
Department of Hematology, Beijing Hospital
Beijing, Beijing Municipality, China Not yet recruiting -
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China Not yet recruiting -
Xinqiao Hospital, Army Military Medical University
Chongqing, China Not yet recruiting
Study contacts
- Principal investigator: Xiao-Hui Zhang, MD — Peking University Institute of Hematology, Peking University People's Hospital
- Study coordinator: Haixia Fu, MD
- Email: fuhaixia_210@163.com
- Phone: 086-01088326002
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ATHNdataset registry for people with bleeding and clotting disorders
This registry collects health, treatment, and patient-reported information from people with bleeding and clotting disorders seen at ATHN-affiliated centers to help improve care and outcomes.
-
Long-term study of blood diseases in patients in China
This study is trying to gather detailed information from patients in China with blood diseases like leukemia and multiple myeloma to better understand how these conditions affect their lives and treatment options.
-
Long-term observation of non-cancer blood disorders
This study is tracking people with blood disorders like hemophilia and thrombosis for at least 15 years to see how their conditions change over time and gather useful information for doctors and researchers.
-
TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization
This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.
-
SR604: a new treatment tested in adults with Hemophilia A/B or congenital Factor VII deficiency
This study tests a single and multiple doses of SR604 to see if it is safe and effective for adults with Hemophilia A or B, with or without inhibitors, and for those with congenital Factor VII deficiency.
-
Mother-and-child hemophilia A program
See if following pregnant people with a severe hemophilia A genotype and their children from pregnancy through early childhood can identify factors linked to maternal bleeding and the child’s development of anti‑FVIII antibodies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.